Browsing by Author Reig, María
Showing results 1 to 9 of 9
| Issue Date | Title | Author(s) |
|---|---|---|
| 28-May-2021 | Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity | Fernández Tussy, Pablo; Rodríguez Agudo, Rubén; Fernández Ramos, David; Barbier Torres, Lucía; Zubiete Franco, Imanol; López de Davalillo, Sergio; Herraez, Elisa; Goikoetxea Usandizaga, Naroa; Lachiondo Ortega, Sofia; Simón, Jorge; Lopitz Otsoa, Fernando; Gutiérrez de Juan, Virginia; Mccain, Misti V.; Perugorria, Maria J.; Mabe, Jon; Navasa, Nicolás; Rodrigues, Cecilia M. P.; Fabregat, Isabel; Boix i Ferrero, Loreto; Sapena, Victor; Anguita, Juan; Lu, Shelly C.; Mato, José M.; Banales, Jesus M.; Villa, Erica; Reeves, Helen L.; Bruix Tudó, Jordi; Reig, María; Marin, Jose J. G.; Delgado, Teresa C.; Martínez Chantar, Maria Luz |
| 30-Mar-2018 | Antiapoptotic BCL-2 proteins determine Sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma | Tutusaus, Anna; Stefanovic, Milica; Boix i Ferrero, Loreto; Cucarull, Blanca; Zamora, Aynara; Blasco, Laura; García de Frutos, Pablo; Reig, María; Fernández-Checa Torres, José Carlos; Marí García, Montserrat; Colell Riera, Anna; Bruix Tudó, Jordi; Morales Muñoz, Albert |
| 2-Jan-2018 | Complete response under sorafenib in patients with hepatocellular carcinoma: Relationship with dermatologic adverse events. | Rimola, Jordi; Díaz González, Álvaro; Reig, María; Darnell, Anna; Varela, María; Pons, Fernando; Hernández Guerra, Manuel; Delgado, Manuel; Castroagudin, Javier; Matilla, Ana; Sangro, Bruno; Rodriguez de Lope, Carlos; Sala, Margarita; Gonzalez, Carmen; Huertas, Carlos; Minguez, Beatriz; Ayuso Colella, Carmen; Bruix Tudó, Jordi |
| 6-Jul-2021 | Early diarrhoea under sorafenib as a marker to consider the early migration to second-line drugs | Díaz González, Álvaro; Sapena, Victor; Boix i Ferrero, Loreto; Torres, Ferram; Sanduzzi-Zamparelli, Marco; Da Fonseca, Leonardo G.; Llarch, Neus; Iserte, Gemma; Guedes, Cassia; Muñoz Martínez, Sergio; Darnell, Anna; Belmonte, Ernest; Rimola, Jordi; Forner, Alejandro; Ayuso Colella, Carmen; Bruix Tudó, Jordi; Reig, María |
| 19-Nov-2020 | Multidisciplinary clinical approach to cancer patients with immune-related adverse events induced by checkpoint inhibitors | Londoño, María Carlota; Reig, María; RETOINMUNOMultidisciplinary Group |
| 14-Nov-2020 | Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab | Reig, María; Galle, Peter R.; Kudo, Masatoshi; Finn, Richard; Llovet i Bayer, Josep Maria; Metti, Andrea L.; Schelman, William R.; Liang, Kun; Wang, Chunxiao; Widau, Ryan C.; Abada, Paolo; Zhu, Andrew X. |
| 17-Dec-2020 | Radiological response to nivolumab in patients with hepatocellular carcinoma: A multicenter analysis of real-life practice | Rimola, Jordi; Da Fonseca, Leonardo G.; Sapena, Victor; Perelló, Chistie; Guerrero, Antonio; Torner Simó, Maria; Pons, Mònica; De la Torre Aláez, Manuel; Calleja Panero, José Luis; Lledó, José L.; Varela, Maria; Mínguez, Beatriz; Sangro, Bruno; Matilla, Ana; Torres, Ferran; Ayuso Colella, Carmen; Bruix Tudó, Jordi; Reig, María; Márquez, Laura |
| 1-Feb-2020 | Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models | Cucarull, Blanca; Tutusaus, Anna; Subias, Miguel; Tutusaus, Anna; Hernáez Alsina, Tania; Boix i Ferrero, Loreto; Reig, María; García de Frutos, Pablo; Marí García, Montserrat; Colell Riera, Anna; Bruix Tudó, Jordi; Morales Muñoz, Albert |
| 29-Jun-2021 | The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma? | Gonzalez Sanchez, Ester; Vaquero, Javier; Férnandez Barrena, Maite G.; Lasarte, Juan José; Avila, Matías A.; Sarobe, Pablo; Reig, María; Calvo, Mariona; Fabregat, Isabel |